Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer. - Wikidata - awgldk - TriplyDB

Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.

Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.

http://www.wikidata.org/entity/Q37629000

about

The role of type II transmembrane serine protease-mediated signaling in cancer.Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.

P2860

Q39015415-AE5226D5-0BE7-4EA0-8DD7-B0B076B3F52C Q51075784-37352F38-B7CC-4187-93BF-AC3200EB9377

P2860

Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.

http://www.wikidata.org/entity/Q37629000

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Matriptase regulates c-Met med ...... in inflammatory breast cancer.

@en

Matriptase regulates c-Met med ...... in inflammatory breast cancer.

@nl

type

label

Matriptase regulates c-Met med ...... in inflammatory breast cancer.

@en

Matriptase regulates c-Met med ...... in inflammatory breast cancer.

@nl

prefLabel

Matriptase regulates c-Met med ...... in inflammatory breast cancer.

@en

Matriptase regulates c-Met med ...... in inflammatory breast cancer.

@nl

P1433

Q37629000-5BDE9883-84E8-45AE-BCE1-14580C17CEFB

P1476

Q37629000-7C0D2FB2-AA69-41B3-870C-B49FDA4A1115

P2093

Q37629000-030367E3-8D76-47E5-8162-F11121B142BD

Q37629000-0EC07CBA-5201-4675-91D4-6240CC93A795

Q37629000-205F240D-CEC2-4483-AEA5-219D2265E459

Q37629000-7D57FBB1-646F-4FFC-B5F2-3986400DA497

Q37629000-989F0B95-0CD1-428E-B445-D8F07F69FF49

Q37629000-9BE2D272-7DC6-4B05-ABBA-B04CF00890CB

Q37629000-9F529CCB-3B7F-45C8-A75D-6CAA506C9E16

Q37629000-AED63261-33F5-46BF-9DE3-B7FC466F6F86

Q37629000-B61E4FB1-7F01-4981-8976-193BD9F28248

Q37629000-DD22BDED-68E0-4165-8F9B-FDE126119E82

P2860

Q37629000-02897709-1FCD-4A0D-868F-52ACF3A0279E

Q37629000-0725C1D1-1676-4302-BFFC-9AB9C3F2249E

Q37629000-0B6D1B6F-C783-4A45-926B-E7AB49B07345

Q37629000-0EE3F87C-508E-4365-9EEB-80953C02E5CA

Q37629000-116DACC1-2CB6-4616-B2EB-76EA168B7A5C

Q37629000-1B6924A5-8196-4234-9962-F785922423CA

Q37629000-23C8A174-63BC-4F20-BE0D-0B4B7000ABAF

Q37629000-284BF9B9-4AF7-4142-B780-AF9520B16FD9

Q37629000-31B73DB8-C5B0-47D1-BAAB-FD8FD1020B08

Q37629000-392F12DE-853E-4B68-ACBE-667B9A626DD2

P304

Q37629000-3E74D736-69E5-48EC-95C2-28B9B9FDDB32

P31

Q37629000-FC2BD964-8C7C-42B4-960D-75D03D48BCC5

P356

Q37629000-6E5EDF57-215C-4A6E-B464-A4F11B442D65

P407

Q37629000-27B532A7-F6E3-4202-A6D2-FF580B4D6264

P433

Q37629000-6771C17E-19B8-494E-84E6-F69DBE999428

P478

Q37629000-481E07FA-8F15-4630-B257-05DD741E98F9

P50

Q37629000-D06C66BD-EE10-4859-857E-CA21594AC648

P577

Q37629000-145D52E2-7B39-4500-9A9D-D44014D5553B

P698

Q37629000-83F01F99-0F24-4D8A-8CA0-2B8E6645DEAC

P932

Q37629000-16126AC9-96A7-4168-A6DB-EAE83549AD25

P356

ONCOTARGET.11262

P1433

P1476

Matriptase regulates c-Met med ...... in inflammatory breast cancer

@en

P2093

Chen-Yong Lin

http://www.w3.org/2001/XMLSchema#string

Eric Marsault

http://www.w3.org/2001/XMLSchema#string

Gina L Zoratti

http://www.w3.org/2001/XMLSchema#string

Julie Boerner

http://www.w3.org/2001/XMLSchema#string

Julie E Lang

http://www.w3.org/2001/XMLSchema#string

Karin List

http://www.w3.org/2001/XMLSchema#string

Michael D Johnson

http://www.w3.org/2001/XMLSchema#string

Michael J Duhaime

http://www.w3.org/2001/XMLSchema#string

Richard Leduc

http://www.w3.org/2001/XMLSchema#string

Thomas E Hyland

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.

Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor

HGF/SF: a potent cytokine for mammary growth, morphogenesis and development

EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK.

Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.

Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.

P304

58162-58173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11262

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Lauren M Tanabe

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27528224

http://www.w3.org/2001/XMLSchema#string

P932

5295421

http://www.w3.org/2001/XMLSchema#string